tryptophan has been researched along with ilomastat in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Golub, LM; Kocer, SS; Simon, SR; Walker, SG; Zerler, B | 1 |
2 other study(ies) available for tryptophan and ilomastat
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cells.
Topics: Animals; Antigens, Bacterial; Bacillus anthracis; Bacterial Toxins; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydroxamic Acids; Indoles; MAP Kinase Kinase 2; MAP Kinase Kinase 6; Metalloproteases; Protein Processing, Post-Translational; Tetracyclines; Tryptophan | 2005 |